AC
WVE icon

Athanor Capital’s Wave Life Sciences WVE Stock Holding History

Athanor Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,451
Closed -$87K – 798
2021
Q1 		$87K Sell
15,451
-17,533
-53% -$168K ﹤0.01% 787
2020
Q4 		$260K Buy
32,984
+12,468
+61% +$105K 0.01% 602
2020
Q3 		$174K Sell
20,516
-15,765
-43% -$173K 0.01% 504
2020
Q2 		$378K Buy
+36,281
New +$341K 0.02% 358
2020
Q1 		– Sell
-34,750
Closed -$279K – 354
2019
Q4 		$279K Buy
34,750
+1,150
+3% +$28.2K 0.01% 320
2019
Q3 		$690K Buy
33,600
+11,900
+55% +$273K 0.04% 135
2019
Q2 		$566K Buy
+21,700
New +$609K 0.07% 92

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Athanor Capital's WVE Position: Q2 2021 in Review

Athanor Capital sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 15,451 shares — an estimated $87K sold.

Athanor Capital first reported a position in WVE in Q2 2019 and held it in 7 quarters. The position peaked at $690K in Q3 2019. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

  • Athanor Capital reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 15,451 Wave Life Sciences shares in Q2 2021, an estimated $87K.
  • Athanor Capital first reported a position in Wave Life Sciences in Q2 2019 and held it in 7 quarters.
  • Athanor Capital's Wave Life Sciences position peaked at $690K in Q3 2019.
  • 87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.